Actigraphy Sensors & PSG Devices Market Outlook Highlights Major Opportunities Likely to Steer Demand during Forecast Period
The US$ 1.78 billion actigraphy
sensor and PSG devices market on course to grow at 4.3% in
2019, according to Fact.MR’s latest analysis. According to the study, actigraphy
sensor and PSG devices market remains a highly consolidated landscape, with
Tier I companies maintaining their hegemony despite the foray of new entrants.
According to the study, as a result of the
convergence of healthcare and technology, new medical technology (MedTech) products
are gaining ground. Growing consumer awareness about—and inclination
towards—technologically advanced actigraphy sensor and PSG devices has
attracted both, tech industry leaders and startups, to enter the healthcare
industry with more innovative actigraphy sensor and PSG devices.
The Fact.MR study provides comprehensive assessment
of the future growth prospects of the actigraphy sensor and PSG devices market
to predict that the market will grow at an incremental 4.6% value CAGE through
2026.
“Ongoing developments and research in the field
of sleep disease diagnostics and management reflect in the huge scope of
innovation in actigraphy sensor and PSG devices. New entrants are aiming to
capitalize on potential opportunities in the actigraphy sensor and PSG devices
market by jumping on the technology bandwagon,” says the Fact.MR
report.
“However,” the report adds, “the
traditional strongholds of the leading players in the actigraphy sensor and PSG
devices—technological expertise and powerful global networks—keep them at the
top of the market. Thereby, even though the new small businesses and startups
are entering the actigraphy sensor and PSG devices market, market leaders will
retain their dominance in the coming future.”
Increased prevalence of sleep-related problems as
well as life-threatening sleep disorders, such as sleep apnea among adults as
well as children is driving the use of high-tech sleep diseases diagnostic
tool. This is expected to have a significant impact on the dynamics of the
actigraphy sensor and PSG devices market in the upcoming years. Manufacturers
in the actigraphy sensor and PSG devices market are integrating next-generation
technologies, such as wireless technologies in actigraphy sensor and PSG devices
to improve the accuracy and reliability of the devices and ultimately to
maintain strong foothold in the market.
Browse Complete Market Report with TOC Here @ https://www.factmr.com/report/2829/actigraphy-sensors-psg-devices-market
The Fact.MR study finds that the latest technological
trends are accelerating the rising number of game-changing actigraphy sensor
and PSG devices being launched across the world. Wireless and USB actigraphy
sensor and PSG devices accounted for more than half the revenue share of the
global market in 2018, according to the study.
Owing to the constant advancements in the wireless
technologies, the trend of growing supply and demand for wireless or USB
actigraphy sensor and PSG devices is likely to persist in the foreseeable
future. Furthermore, growing penetration of wireless medical devices and
diagnostic tools in the healthcare industry in developing countries is creating
lucrative sales opportunities for stakeholders in the actigraphy sensor and PSG
devices market.
Polysomnography Devices to
Remain the Gold Standard for Sleep Monitoring Systems
The Fact.MR study provides a thorough assessment on
various macro and microeconomic factors that are shaping growth of the
actigraphy sensor and PSG devices market. The study finds that polysomnography
or PSG devices hold the largest, nearly 65% revenue share in the actigraphy
sensor and PSG devices market, and the trend is likely to follow through the
coming future.
Polysomnography provides a detailed evaluation of
sleep-related data when it comes to medical cases, which remains the primary
reason behind the growing preference for PSG devices over actigraphy sensors.
In addition, the clinical practice guideline by the American Academy of Sleep
Medicine on use of actigraphy for sleep disorders have declared that
“actigraphy is not a substitute for polysomnography in clinical circumstances”.
Comments
Post a Comment